The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

McKhann, Guy M., Knopman, David S., Chertkow, Howard, Hyman, Bradley T., Jack, Clifford R., Kawas, Claudia H., Klunk, William E., Koroshetz, Walter J. +10 more·2011·Alzheimer's & Dementia

Cited by (1,513)

Items 501–600 of 1,513

  1. Pharmacotherapies for Alzheimer's disease: Beyond cholinesterase inhibitors
    Haythum Osama Tayeb, Hyun Duk Yang, Bruce Heimburger Price, Frank I. Tarazi · 2011 · Pharmacology & Therapeutics
  2. Estimating Alzheimer’s Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia
    Matthew R. Davis, Thomas O`Connell, Scott Johnson, Stephanie K. Cline, Elizabeth P. Merikle, Ferenc Martényi, Kit N. Simpson · 2018 · Current Alzheimer Research
  3. An organization‐ and category‐level comparison of diagnostic requirements for mental disorders in <scp>ICD</scp> ‐11 and <scp>DSM</scp> ‐5
    First, Michael B., Gaebel, Wolfgang, Maj, Mario, Stein, Dan J., Kogan, Cary S., Saunders, John B., Poznyak, Vladimir B., Gureje, Oye, Lewis‐Fernández, Roberto, Maercker, Andreas et al. · 2021 · World Psychiatry
  4. Classification and pathology of primary progressive aphasia
    Jennifer Harris, Claire Gall, J. C. Thompson, Anna M. T. Richardson, D. Neary, Daniel du Plessis, Piyali Pal, David M. A. Mann, Julie S. Snowden, Matthew S. Jones · 2013 · Neurology
  5. Influence of comorbidities in idiopathic normal pressure hydrocephalus — research and clinical care. A report of the ISHCSF task force on comorbidities in INPH
    Jan Malm, Neill R. Graff‐Radford, Masatsune Ishikawa, Bjarne Winther Kristensen, Ville Leinonen, Etsuro Mori, Brian Owler, Mats Tullberg, Michael Allen Williams, Norman R. Relkin · 2013 · Fluids and Barriers of the CNS
  6. Postoperative delirium in elderly patients is associated with subsequent cognitive impairment
    Juraj Šprung, Rosebud O. Roberts, Toby N. Weingarten, Alexandre N. Cavalcante, David S. Knopman, Ronald Carl Petersen, Andrew C. Hanson, Darrell R. Schroeder, David O. Warner · 2017 · British Journal of Anaesthesia
  7. Retinal Microvascular and Neurodegenerative Changes in Alzheimer’s Disease and Mild Cognitive Impairment Compared with Control Participants
    Stephen P. Yoon, Dilraj Singh Grewal, Atalie C. Thompson, Bryce W. Polascik, Cynthia L Dunn, James R. Burke, Sharon Fekrat · 2019 · Ophthalmology Retina
  8. The Effect of a Virtual Reality-Based Intervention Program on Cognition in Older Adults with Mild Cognitive Impairment: A Randomized Control Trial
    Ngeemasara Thapa, Hye Jin Park, Ja‐Gyeong Yang, Haeun Son, Minwoo Jang, Jihyeon Lee, Seung Wan Kang, Kyung Won Park, Kyung Won Park · 2020 · Journal of Clinical Medicine
  9. Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease
    Susanne Ostrowitzki, Tobias Bittner, Kaycee M. Sink, Howard M. Mackey, Christina Rabe, Lawrence S. Honig, Emanuele Cassetta, Michael Woodward, Merçé Boada, Christopher H. van Dyck et al. · 2022 · JAMA Neurology
  10. Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk
    Walker, Keenan A., Chen, Jingsha, Zhang, Jingning, Fornage, Myriam, Yang, Yunju, Zhou, Linda, Grams, Morgan E., Tin, Adrienne, Daya, Natalie, Hoogeveen, Ron C. et al. · 2021 · Nature Aging
  11. Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease
    Lin, Yung-Shuan, Lee, Wei-Ju, Wang, Shuu-Jiun, Fuh, Jong-Ling · 2018 · Scientific Reports
  12. State of the clinical science of perioperative brain health: report from the American Society of Anesthesiologists Brain Health Initiative Summit 2018
    Elizabeth Mahanna, Katie J. Schenning, Lars I. Eriksson, Jeffrey N. Browndyke, Clinton B. Wright, Lisbeth Anne Evered, David A. Scott, Nae Yah Wang, Charles H. Brown, Esther S. Oh et al. · 2019 · British Journal of Anaesthesia
  13. Gut Microbiota Composition Is Related to AD Pathology
    Barbara J. H. Verhaar, Heleen M. A. Hendriksen, Francisca A. de Leeuw, Astrid S. Doorduijn, Mardou S. S. A. van Leeuwenstijn, Charlotte Elisabeth Teunissen, Frederik Barkhof, Philip Scheltens, Robert Kraaij, Cornelia M. van Duijn et al. · 2022 · Frontiers in Immunology
  14. Aging and mental health in the decade ahead: What psychologists need to know
    Karel, Michele J., Gatz, Margaret, Smyer, Michael A. · 2012 · American Psychologist
  15. Multivariate Data Analysis and Machine Learning in Alzheimer's Disease with a Focus on Structural Magnetic Resonance Imaging
    Farshad Falahati, Eric Westman, Andrew Simmons · 2014 · Journal of Alzheimer s Disease
  16. Distinct subtypes of Alzheimer’s disease based on patterns of brain atrophy: longitudinal trajectories and clinical applications
    Daniel Ferreira, C. Verhagen, Juan Andres Hernandez-Cabrera, Lena Cavallin, Chunjie Guo, Urban Ekman, J‐Sebastian Muehlboeck, Andrew Simmons, José Barroso, Lars‐Olof Wahlund et al. · 2017 · Scientific Reports
  17. Imaging biomarkers in neurodegeneration: current and future practices
    Peter N. E. Young, Mar Estarellas, Emma M. Coomans, Meera Srikrishna, Helen Beaumont, Anne Maaß, Ashwin V. Venkataraman, Rikki Lissaman, Daniel Jiménez, Matthew J. Betts et al. · 2020 · Alzheimer s Research & Therapy
  18. Brain FDG PET and the Diagnosis of Dementia
    Shivamurthy, Veeresh K. N., Tahari, Abdel K., Marcus, Charles, Subramaniam, Rathan M. · 2015 · American Journal of Roentgenology
  19. Global Leadership Initiative on Malnutrition (GLIM): Guidance on validation of the operational criteria for the diagnosis of protein-energy malnutrition in adults
    de van der Schueren, M.A.E., Keller, H., Cederholm, T., Barazzoni, R., Compher, C., Correia, M.I.T.D., Gonzalez, M.C., Jager-Wittenaar, H., Pirlich, M., Steiber, A. et al. · 2020 · Clinical Nutrition
  20. Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline
    Pudugramam Murali Doraiswamy, Reisa Anne Sperling, Robert Edward Coleman, Keith A. Johnson, Eric M. Reiman, Mat D. Davis, Michael Grundman, Marwan Noel Sabbagh, Carl Sadowsky, Adam Fleisher et al. · 2012 · Neurology
  21. What Happens with the Circuit in Alzheimer's Disease in Mice and Humans?
    Benedikt Zott, Marc Aurel Busche, Reisa Anne Sperling, Arthur Konnerth · 2018 · Annual Review of Neuroscience
  22. Neuropathologically mixed Alzheimer’s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes
    Lauren Walker, Kirsty E. McAleese, Alan J. Thomas, Mary Ann Johnson, Carmen M. Martin-Ruiz, Craig Parker, Sean J. Colloby, K. A. Jellinger, Johannes Attems · 2015 · Acta Neuropathologica
  23. Epidemiology and Etiology of Alzheimer’s disease: From Genetic to Non- Genetic Factors
    Teng Jiang, Jin‐Tai Yu, Yan Tian, Lan Tan · 2013 · Current Alzheimer Research
  24. Diagnostic and prognostic value of human prion detection in cerebrospinal fluid
    Aaron Foutz, Brian Stephen Appleby, Clive R. Hamlin, Xiaoqin Liu, Sheng Yang, Yvonne Cohen, Wei Chen, Janis E. Blevins, Cameron L. Fausett, Han Wang et al. · 2016 · Annals of Neurology
  25. Poor sleep is associated with CSF biomarkers of amyloid pathology in cognitively normal adults
    Kate E. Sprecher, Rebecca L. Koscik, Cynthia M. Carlsson, Henrik Zetterberg, Kaj Blennow, Ozioma C. Okonkwo, Mark A. Sager, Sanjay Asthana, Sterling C. Johnson, Ruth M. Benca et al. · 2017 · Neurology
  26. Imaging markers for Alzheimer disease
    Giovanni Battista Frisoni, Martina Bocchetta, Gaël Chételat, Gil Dan Rabinovici, Mony J. de Leon, Jeffrey Alan Kaye, Eric M. Reiman, Philip Scheltens, Frederik Barkhof, Sandra E. Black et al. · 2013 · Neurology
  27. Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: A phase 1 clinical trial
    Hee‐Jin Kim, Sang Won Seo, Jong Wook Chang, Jung Il Lee, Chi Hun Kim, Juhee Chin, Soo Jin Choi, Hunki Kwon, Hyuk Jin Yun, Jong Min Lee et al. · 2015 · Alzheimer s & Dementia Translational Research & Clinical Interventions
  28. Frailty syndrome and the risk of vascular dementia: The Italian Longitudinal Study on Aging
    Vincenzo Solfrizzi, Emanuele Scafato, Vincenza Frisardi, Davide Seripa, Giancarlo Logroscino, Stefania Maggi, Bruno Pietro Imbimbo, Lucia Galluzzo, Marzia Baldereschi, Claudia Gandin et al. · 2012 · Alzheimer s & Dementia
  29. Evidence for Ordering of Alzheimer Disease Biomarkers
    Clifford R. Jack · 2011 · Archives of Neurology
  30. Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient identification
    Barthélemy, Nicolas R., Bateman, Randall J., Hirtz, Christophe, Marin, Philippe, Becher, François, Sato, Chihiro, Gabelle, Audrey, Lehmann, Sylvain · 2020 · Alzheimer's Research &amp; Therapy
  31. Predicting Alzheimer disease with β‐amyloid imaging: Results from the Australian imaging, biomarkers, and lifestyle study of ageing
    Rowe, Christopher C., Bourgeat, Pierrick, Ellis, Kathryn A., Brown, Belinda, Lim, Yen Ying, Mulligan, Rachel, Jones, Gareth, Maruff, Paul, Woodward, Michael, Price, Roger et al. · 2013 · Annals of Neurology
  32. Role of EEG as Biomarker in the Early Detection and Classification of Dementia
    Noor Kamal Al-Qazzaz, Sawal Hamid Md Ali, Siti Anom Ahmad, Kalaivani Chellappan, Md. Shabiul Islam, Javier Escudero · 2014 · The Scientific World JOURNAL
  33. Mild Cognitive Impairment: the Manchester consensus
    Ross A. Dunne, Dag Aarsland, John Tiernan O'Brien, Clive G. Ballard, Sube Banerjee, Nick C. Fox, Jeremy Darryl Isaacs, Benjamin R. Underwood, Richard J. Perry, Dennis Chan et al. · 2020 · Age and Ageing
  34. Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease
    Clifford R. Jack, Frederik Barkhof, Matt A. Bernstein, Marc Cantillon, Patricia E. Cole, Charles S DeCarli, Bruno Dubois, Simon Duchesne, Nick C. Fox, Giovanni Battista Frisoni et al. · 2011 · Alzheimer s & Dementia
  35. Magnetic resonance imaging in Alzheimer’s disease neuroimaging initiative 2
    Jack, Clifford R., Barnes, Josephine, Bernstein, Matt A., Borowski, Bret J., Brewer, James, Clegg, Shona, Dale, Anders M., Carmichael, Owen, Ching, Christopher, DeCarli, Charles et al. · 2015 · Alzheimer's &amp; Dementia
  36. Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel
    Claudio Babiloni, Xianghong Arakaki, Hamed Azami, Karim Bennys, Katarzyna Joanna Blinowska, Laura Bonanni, Ana Buján, María C. Carrillo, Andrzej S Cichocki, Jaisalmer de Frutos‐Lucas et al. · 2021 · Alzheimer s & Dementia
  37. A review on advances of treatment modalities for Alzheimer's disease
    Ewen Se Thoe, Ayesha Fauzi, Yin-Quan Tang, Sunita Chamyuang, Adeline Yoke Yin Chia · 2021 · Life Sciences
  38. Early-Onset Familial Alzheimer's Disease (EOFAD)
    Liyong Wu, Pedro Rosa‐Neto, Ging‐Yuek Robin Hsiung, Adele Dessa Sadovnick, Mario Masellis, Sandra E. Black, Jianping Jia, Serge G. Gauthier · 2012 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
  39. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study
    Burnham, Samantha C, Bourgeat, Pierrick, Doré, Vincent, Savage, Greg, Brown, Belinda, Laws, Simon, Maruff, Paul, Salvado, Olivier, Ames, David, Martins, Ralph N et al. · 2016 · The Lancet Neurology
  40. Brief cognitive screening instruments for early detection of Alzheimer's disease: a systematic review
    De Roeck, Ellen Elisa, De Deyn, Peter Paul, Dierckx, Eva, Engelborghs, Sebastiaan · 2019 · Alzheimer's Research &amp; Therapy
  41. Amyloid burden and neural function in people at risk for Alzheimer's Disease
    Johnson, Sterling C., Christian, Bradley T., Okonkwo, Ozioma C., Oh, Jennifer M., Harding, Sandra, Xu, Guofan, Hillmer, Ansel T., Wooten, Dustin W., Murali, Dhanabalan, Barnhart, Todd E. et al. · 2014 · Neurobiology of Aging
  42. Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting
    Daniela Perani, Pasquale Anthony Della Rosa, Chiara Cerami, Francesca Gallivanone, Federico Fallanca, Emilia Giovanna Vanoli, Andrea Panzacchi, Flavio Mariano Nobili, Sabina Pappatà, Alessandra Marcone et al. · 2014 · NeuroImage Clinical
  43. Plasma Biomarkers Associated With the Apolipoprotein E Genotype and Alzheimer Disease
    Soares, Holly D. · 2012 · Archives of Neurology
  44. Oxidative Stress and Dementia in Alzheimer’s Patients: Effects of Synbiotic Supplementation
    Alyne Mendonça Marques Ton, Bianca Prandi Campagnaro, Gisela Aleixo Alves, Rafaela Aires, Larissa Zambom Côco, Clarisse Máximo Arpini, Trícia Guerra e Oliveira, Manuel Campos‐Toimil, Silvana S. Meyrelles, Thiago de Melo Costa Pereira et al. · 2020 · Oxidative Medicine and Cellular Longevity
  45. Cerebrospinal fluid tau and amyloid-β1-42in patients with dementia
    Tobias Borgh Skillbäck, Bahman Y. Farahmand, Christoffer Rosén, Niklas Mattsson, Katarina Nägga, Lena Kilander, Dorota Religa, Anders B. Wimo, Bengt G. Winblad, Jonathan M. Schott et al. · 2015 · Brain
  46. ‘Kitchen and cooking,’ a serious game for mild cognitive impairment and Alzheimer’s disease: a pilot study
    Valéria Manera, Pierre‐David Petit, Alexandre Derreumaux, Ivan Orvieto, Matteo Romagnoli, Graham Lyttle, Renaud David, Philippe Henri Robert · 2015 · Frontiers in Aging Neuroscience
  47. Ageing Process and Physiological Changes
    Shilpa Amarya, Kalyani Singh, M. Sabharwal · 2018 · Gerontology
  48. Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer’s disease
    Morris, Gary P., Clark, Ian A., Vissel, Bryce · 2018 · Acta Neuropathologica
  49. A Bayesian network decision model for supporting the diagnosis of dementia, Alzheimer's disease and mild cognitive impairment
    F. Seixas, B. Zadrozny, J. Laks, A. Conci, D. Muchaluat-Saade · 2014 · Comput. Biol. Medicine
  50. Clinical diagnostic utility of transcranial magnetic stimulation in neurological disorders. Updated report of an IFCN committee
    Steve Vucic, Kai-Hsiang Stanley Chen, Matthew C. Kiernan, Mark Hallett, David H Benninger, Vincenzo Di Lazzaro, Paolo Maria Rossini, Alberto Benussi, Alfredo Berardelli, Antonio Currà et al. · 2023 · Clinical Neurophysiology
  51. The cortical origin and initial spread of medial temporal tauopathy in Alzheimer’s disease assessed with positron emission tomography
    Sanchez, Justin S., Becker, J. Alex, Jacobs, Heidi I. L., Hanseeuw, Bernard J., Jiang, Shu, Schultz, Aaron P., Properzi, Michael J., Katz, Samantha R., Beiser, Alexa, Satizabal, Claudia L. et al. · 2021 · Science Translational Medicine
  52. Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease
    Rawan M. Tarawneh, Gina D’Angelo, Dan L. Crimmins, Elizabeth M. Herries, Terry A. Griest, Anne M. Fagan, Gregory Joseph Zipfel, Jack H. Ladenson, John C. Morris, David M. Holtzman · 2016 · JAMA Neurology
  53. Loneliness Increases the Risk of All-Cause Dementia and Alzheimer’s Disease
    Anna Sundström, Annelie Nordin Adolfsson, Maria Nordin, Rolf Adolfsson · 2019 · The Journals of Gerontology Series B
  54. Alzheimer's disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges
    Saeid Safiri, Amir Ghaffari Jolfayi, Asra Fazlollahi, Soroush Morsali, Aila Sarkesh, Amin Daei Sorkhabi, Behnam Golabi, Reza Aletaha, Kimia Motlagh Asghari, Sana Hamidi et al. · 2024 · Frontiers in Medicine
  55. Fluid biomarkers in Alzheimer’s disease – current concepts
    Christoffer Rosén, Oskar Hansson, Kaj Blennow, Henrik Zetterberg · 2013 · Molecular Neurodegeneration
  56. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment
    Lombardi, Gemma, Crescioli, Giada, Cavedo, Enrica, Lucenteforte, Ersilia, Casazza, Giovanni, Bellatorre, Alessandro-Giacco, Lista, Chiara, Costantino, Giorgio, Frisoni, Giovanni, Virgili, Gianni et al. · 2020 · Cochrane Database of Systematic Reviews
  57. The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer’s Disease
    Hays, Chelsea C., Zlatar, Zvinka Z., Wierenga, Christina E. · 2016 · Cellular and Molecular Neurobiology
  58. Fluid Biomarkers in Alzheimer Disease
    Blennow, K., Zetterberg, H., Fagan, A. M. · 2012 · Cold Spring Harbor Perspectives in Medicine
  59. The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes
    Jack, Clifford R, Wiste, Heather J, Botha, Hugo, Weigand, Stephen D, Therneau, Terry M, Knopman, David S, Graff-Radford, Jonathan, Jones, David T, Ferman, Tanis J, Boeve, Bradley F et al. · 2019 · Brain
  60. Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer’s disease: a pilot study
    B. Neth, A. Mintz, Christopher T. Whitlow, Youngkyoo Jung, K. Sai, T. Register, D. Kellar, S. Lockhart, S. Hoscheidt, J. Maldjian et al. · 2019 · Neurobiology of Aging
  61. Drug and Exercise Treatment of Alzheimer Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Effects on Cognition in Randomized Controlled Trials
    Andreas Ströhle, Dietlinde K. Schmidt, Florian Schultz, Nina Fricke, Theresa Staden, Rainer Hellweg, Josef Priller, Michael A. Rapp, Nina Rieckmann · 2015 · American Journal of Geriatric Psychiatry
  62. Multiscale deep neural network based analysis of FDG-PET images for the early diagnosis of Alzheimer’s disease
    Donghuan Lu, Karteek Popuri, Gavin Weiguang Ding, Rakesh Balachandar, Mirza Faisal Beg · 2018 · Medical Image Analysis
  63. Knowledge domain and emerging trends in Alzheimer’s disease: a scientometric review based on CiteSpace analysis
    Shuo Liu, Ya-Ping Sun, Xu-Ling Gao, Yi Sui · 2019 · Neural Regeneration Research
  64. Diffusion tensor imaging of white matter degeneration in Alzheimer’s disease and mild cognitive impairment
    Amlien, I.K., Fjell, A.M. · 2014 · Neuroscience
  65. Unbiased Approach to Counteract Upward Drift in Cerebrospinal Fluid Amyloid-β 1–42 Analysis Results
    Betty Marije Tijms, Eline A.J. Willemse, Marissa Deborah Zwan, Sandra D. Mulder, Pieter Jelle Visser, Bart N.M. van Berckel, Wiesje M. van der Flier, Philip Scheltens, Charlotte Elisabeth Teunissen · 2017 · Clinical Chemistry
  66. Sensor-Based Datasets for Human Activity Recognition – A Systematic Review of Literature
    Emiro De-La-Hoz-Franco, Paola Ariza-Colpas, Javier Medina-Quero, Macarena Espinilla · 2018 · IEEE Access
  67. Sleep in Alzheimer’s disease: a systematic review and meta-analysis of polysomnographic findings
    Ye Zhang, Rong Ren, Linghui Yang, Haipeng Zhang, Yuan Shi, Hamid Reza Okhravi, Michael V. Vitiello, Larry D. Sanford, Xiangdong Tang · 2022 · Translational Psychiatry
  68. Designing the next-generation clinical care pathway for Alzheimer’s disease
    Hampel, Harald, Au, Rhoda, Mattke, Soeren, van der Flier, Wiesje M., Aisen, Paul, Apostolova, Liana, Chen, Christopher, Cho, Min, De Santi, Susan, Gao, Peng et al. · 2022 · Nature Aging
  69. Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer’s disease
    Wang, Hong, Dey, Kaushik Kumar, Chen, Ping-Chung, Li, Yuxin, Niu, Mingming, Cho, Ji-Hoon, Wang, Xusheng, Bai, Bing, Jiao, Yun, Chepyala, Surendhar Reddy et al. · 2020 · Molecular Neurodegeneration
  70. Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer’s disease
    Holstege, Henne, Hulsman, Marc, Charbonnier, Camille, Grenier-Boley, Benjamin, Quenez, Olivier, Grozeva, Detelina, van Rooij, Jeroen G. J., Sims, Rebecca, Ahmad, Shahzad, Amin, Najaf et al. · 2022 · Nature Genetics
  71. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer’s disease
    Yen Ying Lim, Paul T. Maruff, Robert H. Pietrzak, David J. Ames, Kathryn A. Ellis, Karra Harrington, Nicola T. Lautenschlager, Cassandra E. I. Szoeke, Ralph Nigel Martins, Colin Louis Masters et al. · 2013 · Brain
  72. Cross-Cultural Applicability of the Montreal Cognitive Assessment (MoCA): A Systematic Review
    C. O'Driscoll, M. Shaikh · 2017 · Journal of Alzheimer's Disease
  73. Oral hygiene and oral health in older people with dementia: a comprehensive review with focus on oral soft tissues
    Suzanne Delwel, Tarik T. Binnekade, Roberto S.G.M. Perez, Cees M.P.M. Hertogh, Erik Scherder, Frank Lobbezoo · 2017 · Clinical Oral Investigations
  74. European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18F‐fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus
    Flavio Mariano Nobili, Javier Arbizu, Femke H. Bouwman, Alexander E. Drzezga, Federica Agosta, Peter J. Nestor, Zuzana Walker, Marina Boccardi, the EANM‐EAN Task Force for the Prescription of FDG‐PET for Dementing Neurodegenerative Disorders · 2018 · European Journal of Neurology
  75. Communication Difficulties as a Result of Dementia
    2018 · Materia Socio Medica
  76. Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial
    Cummings, Jeffrey L., Lyketsos, Constantine G., Peskind, Elaine R., Porsteinsson, Anton P., Mintzer, Jacobo E., Scharre, Douglas W., De La Gandara, Jose E., Agronin, Marc, Davis, Charles S., Nguyen, Uyen et al. · 2015 · JAMA
  77. Genetics of Alzheimer’s Disease
    Vincent Antoine Chouraki, Sudha S. Seshadri · 2014 · Advances in genetics
  78. CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)
    Craig William Ritchie, Nadja Smailagic, Anna H Noel-Storr, Obioha Chukwunyere Ukoumunne, Emma C Ladds, Steven Martin · 2017 · Cochrane Database of Systematic Reviews
  79. Regional brain stiffness changes across the Alzheimer's disease spectrum
    Matthew C. Murphy, David Thomas Jones, Clifford R. Jack, Kevin J. Glaser, Matthew L. Senjem, Armando Manduca, Joel P. Felmlee, Rickey E. Carter, Richard L. Ehman, John Huston · 2015 · NeuroImage Clinical
  80. 18F-AV-1451 positron emission tomography in Alzheimer’s disease and progressive supranuclear palsy
    Luca Passamonti, Patricia Vázquez Rodríguez, Young T. Hong, Kieren S. J. Allinson, David Williamson, Robin Jacob Borchert, Saber A. K. Sami, Thomas Cope, William Richard Bevan-Jones, Peter Simon Jones et al. · 2016 · Brain
  81. Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging
    Michelle M. Mielke, Clinton E. Hagen, Alexandra M. V. Wennberg, David C. Airey, Rodolfo Savica, David S. Knopman, Mary M. Machulda, Rosebud O. Roberts, Clifford R. Jack, Ronald Carl Petersen et al. · 2017 · JAMA Neurology
  82. Subtyping of circulating exosome-bound amyloid β reflects brain plaque deposition
    Lim, Carine Z. J., Zhang, Yan, Chen, Yu, Zhao, Haitao, Stephenson, Mary C., Ho, Nicholas R. Y., Chen, Yuan, Chung, Jaehoon, Reilhac, Anthonin, Loh, Tze Ping et al. · 2019 · Nature Communications
  83. Sleep characteristics and risk of dementia and Alzheimer's disease: The Atherosclerosis Risk in Communities Study
    Lutsey, Pamela L., Misialek, Jeffrey R., Mosley, Thomas H., Gottesman, Rebecca F., Punjabi, Naresh M., Shahar, Eyal, MacLehose, Richard, Ogilvie, Rachel P., Knopman, David, Alonso, Alvaro · 2018 · Alzheimer's &amp; Dementia
  84. Developing an international network for Alzheimer’s research: the Dominantly Inherited Alzheimer Network
    John C. Morris, Paul S. S Aisen, Randall John Bateman, Tammie L.S. Benzinger, Nigel J. Cairns, Anne M. Fagan, Bernardino Francesco Ghetti, Alison Goate, David M. Holtzman, William Edward Klunk et al. · 2012 · Clinical Investigation
  85. Deep learning-based brain age prediction in normal aging and dementia
    Jeyeon Lee, Brian J. Burkett, Hoon-Ki Paul Min, Matthew L. Senjem, Emily S. Lundt, Hugo Botha, Jonathan Graff‐Radford, Leland R Barnard, Jeffrey L. Gunter, Christopher G. Schwarz et al. · 2022 · Nature Aging
  86. Dementia Prevention and Treatment
    David B. Reuben, Sarah A. Kremen, Donovan T. Maust · 2024 · JAMA Internal Medicine
  87. Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage
    Simon‐Shlomo Poil, Willem de Haan, Wiesje M. van der Flier, Huibert D. Mansvelder, Philip Scheltens, Klaus Linkenkaer‐Hansen · 2013 · Frontiers in Aging Neuroscience
  88. AlzheimerNet: An Effective Deep Learning Based Proposition for Alzheimer’s Disease Stages Classification From Functional Brain Changes in Magnetic Resonance Images
    F. M. Javed Mehedi Shamrat, Shamima Akter, Sami Azam, Asif Karim, Pronab Ghosh, Zarrin Tasnim, Khan Md. Hasib, Friso De Boer, Kawsar Ahmed · 2023 · IEEE Access
  89. Regional Magnetic Resonance Imaging Measures for Multivariate Analysis in Alzheimer’s Disease and Mild Cognitive Impairment
    Eric Westman, Carlos Aguilar, J‐Sebastian Muehlboeck, Andrew Simmons · 2012 · Brain Topography
  90. Cognitive reserve and long-term change in cognition in aging and preclinical Alzheimer's disease
    Anja Soldan, Corinne A. Pettigrew, Qing Cai, Jiangxia Wang, Mei‐Cheng Wang, Abhay Moghekar, Michael I. Miller, Marilyn Albert · 2017 · Neurobiology of Aging
  91. Alzheimer’s disease: clinical update on epidemiology, pathophysiology and diagnosis
    Dhamidhu Eratne, Samantha M. Loi, Sarah Farrand, Wendy M. Kelso, Dennis Velakoulis, Jeffrey CL Looi · 2018 · Australasian Psychiatry
  92. Plasma phospho-tau217 for Alzheimer’s disease diagnosis in primary and secondary care using a fully automated platform
    Sebastian Palmqvist, Noëlle Warmenhoven, Federica Anastasi, Andrea Pilotto, Shorena Janelidze, Pontus Tideman, Erik Stomrud, Niklas Mattsson, Ruben A Smith, Rik Ossenkoppele et al. · 2025 · Nature Medicine
  93. HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer’s disease
    Festoff, Barry W., Sajja, Ravi K., van Dreden, Patrick, Cucullo, Luca · 2016 · Journal of Neuroinflammation
  94. 18 F-FDG PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)
    Nadja Smailagic, Marco Vacante, Chris Hyde, Steven Martin, Obioha Chukwunyere Ukoumunne, Christos Sachpekidis · 2015 · Cochrane Database of Systematic Reviews
  95. Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer’s disease
    Alaina Baker‐Nigh, Shahrooz Vahedi, Elena Davis, Sandra Weıntraub, Eileen H. Bigio, William L. Klein, Changiz Geula · 2015 · Brain
  96. Transcranial direct current stimulation in mild cognitive impairment: Behavioral effects and neural mechanisms
    M. Meinzer, R. Lindenberg, Mai Thy Phan, L. Ulm, C. Volk, A. Flöel · 2015 · Alzheimer's & Dementia
  97. Recommendations for the use of Serious Games in people with Alzheimer's Disease, related disorders and frailty
    Philippe Henri Robert, Alexandra König, Hélène Amieva, Sandrine Andrieu, François Brémond, Roger Alan Bullock, Mathieu Pierre Ceccaldi, Bruno Dubois, Serge G. Gauthier, Paul-Ariel Kenigsberg et al. · 2014 · Frontiers in Aging Neuroscience
  98. Network-selective vulnerability of the human cerebellum to Alzheimer’s disease and frontotemporal dementia
    Christine Cong Guo, Rachel H. Tan, John R. Hodges, Xintao Hu, Saber A. K. Sami, Michael Hornberger · 2016 · Brain
  99. Altered Macular Microvasculature in Mild Cognitive Impairment and Alzheimer Disease
    Hong Jiang, Yantao Wei, Yingying Shi, Clinton B. Wright, Xiaoyan Sun, Giovanni Gregori, Fang Zheng, Elizabeth A. Vanner, Byron L. Lam, Tatjana Rundek et al. · 2017 · Journal of Neuro-Ophthalmology
  100. Assessment tools to evaluate Activities of Daily Living (ADL) and Instrumental Activities of Daily Living (IADL) in older adults: A systematic review.
    Marzieh Pashmdarfard, Akram Azad · 2020 · PubMed Central